Exploring Post-Pandemic Medical Manufacturing: Assessing Opportunities for Innovation, and Growth.
​In the aftermath of the global pandemic, the medical manufacturing landscape has undergone significant changes, posing challenges and opportunities for industry players. As we navigate the post-pandemic era, it is crucial to assess potential avenues for innovation, growth, and expansion within the sector.
This exploration aims to delve into the intricate dynamics of the industry, shedding light on evolving demands, technological advancements, and regulatory considerations shaping the future of medical manufacturing. Through a comprehensive analysis, we aim to guide industry stakeholders in leveraging the transformative period, contributing to global healthcare infrastructure resilience and advancement.
This session provides a platform for established and prospective industry players to connect with leading experts, exploring the post-pandemic medical manufacturing landscape. Topics include regulatory dynamics affecting the medical value chain, challenges, and global collaboration initiatives. Insights into post-pandemic opportunities, innovative technologies, and untapped market prospects will be discussed. Conversations will also cover supply chain localization, expansion prospects, export potential, funding solutions, and government-led efforts supporting small and medium-sized enterprises. The session aims to foster knowledge exchange, cultivating innovative and sustainable manufacturing concepts with potential operations within the Special Economic Zone (SEZ) and beyond.
Understanding Regulatory Dynamics in Manufacturing:
· Discuss how regulatory frameworks governing the medical industry have evolved in response to the pandemic.
· Address the regulatory challenges faced by medical manufacturers in bringing new products to market post-pandemic.
· Highlight initiatives aimed at promoting global collaboration and standardisation in the medical industry post-pandemic. Discuss the role of international organisations, regulatory bodies, and industry associations in harmonizing standards, sharing best practices, and facilitating cross-border trade in medical products.
Host:
- Nishan Pillay, CEO, Fractional
Speakers:
- Maidei Matika, Chief Investment Officer, OR Tambo SEZ; and
- Zanele Fakude, Trade & Export Dev. Head, Gauteng Growth and
- Graham Blackbeard, Managing Director, Southern Implants